Crestovo Investor Llc - Net Worth and Insider Trading

Crestovo Investor Llc Net Worth

The estimated net worth of Crestovo Investor Llc is at least $809,052 dollars as of 2024-05-16. Crestovo Investor Llc is the Director, 10% Owner of Finch Therapeutics Group Inc and owns about 421,381 shares of Finch Therapeutics Group Inc (FNCH) stock worth over $809,052. Details can be seen in Crestovo Investor Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Crestovo Investor Llc has not made any transactions after 2021-03-23 and currently still holds the listed stock(s).

Transaction Summary of Crestovo Investor Llc

To

Crestovo Investor Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Crestovo Investor Llc owns 1 companies in total, including Finch Therapeutics Group Inc (FNCH) .

Click here to see the complete history of Crestovo Investor Llc’s form 4 insider trades.

Insider Ownership Summary of Crestovo Investor Llc

Ticker Comapny Transaction Date Type of Owner
FNCH Finch Therapeutics Group Inc 2021-03-23 director & 10 percent owner

Crestovo Investor Llc Latest Holdings Summary

Crestovo Investor Llc currently owns a total of 1 stock. Crestovo Investor Llc owns 421,381 shares of Finch Therapeutics Group Inc (FNCH) as of March 23, 2021, with a value of $809,052.

Latest Holdings of Crestovo Investor Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FNCH Finch Therapeutics Group Inc 2021-03-23 421,381 1.92 809,052

Holding Weightings of Crestovo Investor Llc


Crestovo Investor Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Crestovo Investor Llc has made a total of 1 transactions in Finch Therapeutics Group Inc (FNCH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Finch Therapeutics Group Inc is the acquisition of 24,510 shares on March 23, 2021, which cost Crestovo Investor Llc around $13 Million.

Insider Trading History of Crestovo Investor Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Crestovo Investor Llc Trading Performance

GuruFocus tracks the stock performance after each of Crestovo Investor Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Crestovo Investor Llc is -1.26%. GuruFocus also compares Crestovo Investor Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Crestovo Investor Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Crestovo Investor Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Crestovo Investor Llc

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.92
Relative Return to S&P 500(%) -22.82

Crestovo Investor Llc Ownership Network

Ownership Network List of Crestovo Investor Llc

No Data

Ownership Network Relation of Crestovo Investor Llc


Crestovo Investor Llc Owned Company Details

What does Finch Therapeutics Group Inc do?

Who are the key executives at Finch Therapeutics Group Inc?

Crestovo Investor Llc is the director & 10 percent owner of Finch Therapeutics Group Inc. Other key executives at Finch Therapeutics Group Inc include Chief Financial Officer Lance E Thibault , Chief Executive Officer Matthew P. Blischak , and Chief Business & Legal Officer Joseph Vittiglio .

Finch Therapeutics Group Inc (FNCH) Insider Trades Summary

Over the past 18 months, Crestovo Investor Llc made no insider transaction in Finch Therapeutics Group Inc (FNCH). Other recent insider transactions involving Finch Therapeutics Group Inc (FNCH) include a net sale of 9,712 shares made by Jeffery A Smisek , and a net purchase of 5,010 shares made by Susan E Graf .

In summary, during the past 3 months, insiders sold 8,242 shares of Finch Therapeutics Group Inc (FNCH) in total and bought 0 shares, with a net sale of 8,242 shares. During the past 18 months, 9,712 shares of Finch Therapeutics Group Inc (FNCH) were sold and 167 shares were bought by its insiders, resulting in a net sale of 9,545 shares.

Finch Therapeutics Group Inc (FNCH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Finch Therapeutics Group Inc Insider Transactions

No Available Data

Crestovo Investor Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Crestovo Investor Llc. You might contact Crestovo Investor Llc via mailing address: 28 Havemeyer Place, Greenwich Ct 06830.

Discussions on Crestovo Investor Llc

No discussions yet.